Relapsed or Refractory Hematologic Malignancies Clinical Trials

6 clinical trials for Relapsed or Refractory Hematologic Malignancies across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies — RECRUITING · PHASE1
• A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies — RECRUITING · PHASE1
• A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies — RECRUITING · PHASE1
• Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies — NOT_YET_RECRUITING · PHASE1
• Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) — COMPLETED · PHASE1
• A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies — NOT_YET_RECRUITING · PHASE1

Refine this search